Wellell Inc. (TPE:4106)
Taiwan · Delayed Price · Currency is TWD 22.30
-0.10 (-0.45%)
At close: Mar 27, 2026
Wellell Revenue
In the year 2025, Wellell had annual revenue of 2.40B TWD with 0.74% growth. Wellell had revenue of 624.48M in the quarter ending December 31, 2025, with 1.76% growth.
Revenue
2.40B
Revenue Growth
+0.74%
P/S Ratio
0.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.40B | 17.68M | 0.74% |
| Dec 31, 2024 | 2.39B | -260.47M | -9.84% |
| Dec 31, 2023 | 2.65B | -16.60M | -0.62% |
| Dec 31, 2022 | 2.66B | 289.67M | 12.20% |
| Dec 31, 2021 | 2.37B | 370.03M | 18.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| Cowealth Medical Holding | 3.41B |
| OK Biotech | 1.56B |
| Dynamic Medical Technologies | 1.39B |
| WeLeader Biomedical | 1.11B |
| Bioptik Technology Incorporation | 837.19M |
| A Plus Biotechnology | 835.89M |
| Diamond Biotechnology | 698.11M |